Filing Details
- Accession Number:
- 0001181431-13-058489
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-11-12 21:36:40
- Reporting Period:
- 2013-11-08
- Filing Date:
- 2013-11-12
- Accepted Time:
- 2013-11-12 21:36:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1415336 | Zeltiq Aesthetics Inc | ZLTQ | Electromedical & Electrotherapeutic Apparatus (3845) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1562195 | Carl Lamm | 4698 Willow Road Pleasanton CA 94588 | Vp Of Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-11-08 | 7,310 | $11.30 | 26,156 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-11-08 | 7,310 | $16.00 | 18,846 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to buy) | Disposition | 2013-11-08 | 7,310 | $0.00 | 7,310 | $11.30 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
10,234 | 2022-02-16 | No | 4 | M | Direct |
Footnotes
- The sale reported in this Form 4 was affected pursuant to the Rule 10b5-1 trading plan adopted by the Reporting Person on August 29, 2013.
- 25% of the granted 17,544 shares underlying this option became exercisable on 2/17/2013, and the remainder vest in equal monthly installments over a 36-month period thereafter, subject to the Reporting Person's continued service to the Issuer.